Boston Scientific Corporation BSX recently presented data supporting the use of the FARAPULSE Pulsed Field Ablation (“PFA”) ...
T-cell therapy, originally developed for haematological malignancies, has recently emerged as a promising therapy for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback